Global Tumor NGS Detection Market Research Report 2024(Status and Outlook)
Report Overview:
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
The Global Tumor NGS Detection Market Size was estimated at USD 2128.46 million in 2023 and is projected to reach USD 5132.36 million by 2029, exhibiting a CAGR of 15.80% during the forecast period.
This report provides a deep insight into the global Tumor NGS Detection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tumor NGS Detection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tumor NGS Detection market in any manner.
Global Tumor NGS Detection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent
Thermo Fisher Scientific
BGI Group
Roche Foundation Medicine
Sinopharm Group
Fosunpharma
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
Perkin Elmer
Qiagen NV
Partek
Illumina Inc.
Pacific Biosciences of California Inc.
Life Technologies Corporation
GTH.O
Paradigm Diagnostics
Oxford Nanopore Technologies Ltd.
Eurofins Scientific S.E.
Market Segmentation (by Type)
Medical Equipment
Consumables
Market Segmentation (by Application)
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor NGS Detection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The main purpose of NGS is to discover clinically treatable genetic variants and guide patient treatment.
The Global Tumor NGS Detection Market Size was estimated at USD 2128.46 million in 2023 and is projected to reach USD 5132.36 million by 2029, exhibiting a CAGR of 15.80% during the forecast period.
This report provides a deep insight into the global Tumor NGS Detection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tumor NGS Detection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tumor NGS Detection market in any manner.
Global Tumor NGS Detection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent
Thermo Fisher Scientific
BGI Group
Roche Foundation Medicine
Sinopharm Group
Fosunpharma
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
Perkin Elmer
Qiagen NV
Partek
Illumina Inc.
Pacific Biosciences of California Inc.
Life Technologies Corporation
GTH.O
Paradigm Diagnostics
Oxford Nanopore Technologies Ltd.
Eurofins Scientific S.E.
Market Segmentation (by Type)
Medical Equipment
Consumables
Market Segmentation (by Application)
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Tumor NGS Detection Market
- Overview of the regional outlook of the Tumor NGS Detection Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor NGS Detection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Tumor NGS Detection
1.2 Key Market Segments
1.2.1 Tumor NGS Detection Segment by Type
1.2.2 Tumor NGS Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUMOR NGS DETECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tumor NGS Detection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tumor NGS Detection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUMOR NGS DETECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Tumor NGS Detection Sales by Manufacturers (2019-2024)
3.2 Global Tumor NGS Detection Revenue Market Share by Manufacturers (2019-2024)
3.3 Tumor NGS Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tumor NGS Detection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tumor NGS Detection Sales Sites, Area Served, Product Type
3.6 Tumor NGS Detection Market Competitive Situation and Trends
3.6.1 Tumor NGS Detection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tumor NGS Detection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TUMOR NGS DETECTION INDUSTRY CHAIN ANALYSIS
4.1 Tumor NGS Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUMOR NGS DETECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TUMOR NGS DETECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor NGS Detection Sales Market Share by Type (2019-2024)
6.3 Global Tumor NGS Detection Market Size Market Share by Type (2019-2024)
6.4 Global Tumor NGS Detection Price by Type (2019-2024)
7 TUMOR NGS DETECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor NGS Detection Market Sales by Application (2019-2024)
7.3 Global Tumor NGS Detection Market Size (M USD) by Application (2019-2024)
7.4 Global Tumor NGS Detection Sales Growth Rate by Application (2019-2024)
8 TUMOR NGS DETECTION MARKET SEGMENTATION BY REGION
8.1 Global Tumor NGS Detection Sales by Region
8.1.1 Global Tumor NGS Detection Sales by Region
8.1.2 Global Tumor NGS Detection Sales Market Share by Region
8.2 North America
8.2.1 North America Tumor NGS Detection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tumor NGS Detection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tumor NGS Detection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tumor NGS Detection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tumor NGS Detection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent
9.1.1 Agilent Tumor NGS Detection Basic Information
9.1.2 Agilent Tumor NGS Detection Product Overview
9.1.3 Agilent Tumor NGS Detection Product Market Performance
9.1.4 Agilent Business Overview
9.1.5 Agilent Tumor NGS Detection SWOT Analysis
9.1.6 Agilent Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Tumor NGS Detection Basic Information
9.2.2 Thermo Fisher Scientific Tumor NGS Detection Product Overview
9.2.3 Thermo Fisher Scientific Tumor NGS Detection Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific Tumor NGS Detection SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 BGI Group
9.3.1 BGI Group Tumor NGS Detection Basic Information
9.3.2 BGI Group Tumor NGS Detection Product Overview
9.3.3 BGI Group Tumor NGS Detection Product Market Performance
9.3.4 BGI Group Tumor NGS Detection SWOT Analysis
9.3.5 BGI Group Business Overview
9.3.6 BGI Group Recent Developments
9.4 Roche Foundation Medicine
9.4.1 Roche Foundation Medicine Tumor NGS Detection Basic Information
9.4.2 Roche Foundation Medicine Tumor NGS Detection Product Overview
9.4.3 Roche Foundation Medicine Tumor NGS Detection Product Market Performance
9.4.4 Roche Foundation Medicine Business Overview
9.4.5 Roche Foundation Medicine Recent Developments
9.5 Sinopharm Group
9.5.1 Sinopharm Group Tumor NGS Detection Basic Information
9.5.2 Sinopharm Group Tumor NGS Detection Product Overview
9.5.3 Sinopharm Group Tumor NGS Detection Product Market Performance
9.5.4 Sinopharm Group Business Overview
9.5.5 Sinopharm Group Recent Developments
9.6 Fosunpharma
9.6.1 Fosunpharma Tumor NGS Detection Basic Information
9.6.2 Fosunpharma Tumor NGS Detection Product Overview
9.6.3 Fosunpharma Tumor NGS Detection Product Market Performance
9.6.4 Fosunpharma Business Overview
9.6.5 Fosunpharma Recent Developments
9.7 Novogene
9.7.1 Novogene Tumor NGS Detection Basic Information
9.7.2 Novogene Tumor NGS Detection Product Overview
9.7.3 Novogene Tumor NGS Detection Product Market Performance
9.7.4 Novogene Business Overview
9.7.5 Novogene Recent Developments
9.8 Geneseeq
9.8.1 Geneseeq Tumor NGS Detection Basic Information
9.8.2 Geneseeq Tumor NGS Detection Product Overview
9.8.3 Geneseeq Tumor NGS Detection Product Market Performance
9.8.4 Geneseeq Business Overview
9.8.5 Geneseeq Recent Developments
9.9 AmoyDx
9.9.1 AmoyDx Tumor NGS Detection Basic Information
9.9.2 AmoyDx Tumor NGS Detection Product Overview
9.9.3 AmoyDx Tumor NGS Detection Product Market Performance
9.9.4 AmoyDx Business Overview
9.9.5 AmoyDx Recent Developments
9.10 Burning Rock Medicine
9.10.1 Burning Rock Medicine Tumor NGS Detection Basic Information
9.10.2 Burning Rock Medicine Tumor NGS Detection Product Overview
9.10.3 Burning Rock Medicine Tumor NGS Detection Product Market Performance
9.10.4 Burning Rock Medicine Business Overview
9.10.5 Burning Rock Medicine Recent Developments
9.11 Perkin Elmer
9.11.1 Perkin Elmer Tumor NGS Detection Basic Information
9.11.2 Perkin Elmer Tumor NGS Detection Product Overview
9.11.3 Perkin Elmer Tumor NGS Detection Product Market Performance
9.11.4 Perkin Elmer Business Overview
9.11.5 Perkin Elmer Recent Developments
9.12 Qiagen NV
9.12.1 Qiagen NV Tumor NGS Detection Basic Information
9.12.2 Qiagen NV Tumor NGS Detection Product Overview
9.12.3 Qiagen NV Tumor NGS Detection Product Market Performance
9.12.4 Qiagen NV Business Overview
9.12.5 Qiagen NV Recent Developments
9.13 Partek
9.13.1 Partek Tumor NGS Detection Basic Information
9.13.2 Partek Tumor NGS Detection Product Overview
9.13.3 Partek Tumor NGS Detection Product Market Performance
9.13.4 Partek Business Overview
9.13.5 Partek Recent Developments
9.14 Illumina Inc.
9.14.1 Illumina Inc. Tumor NGS Detection Basic Information
9.14.2 Illumina Inc. Tumor NGS Detection Product Overview
9.14.3 Illumina Inc. Tumor NGS Detection Product Market Performance
9.14.4 Illumina Inc. Business Overview
9.14.5 Illumina Inc. Recent Developments
9.15 Pacific Biosciences of California Inc.
9.15.1 Pacific Biosciences of California Inc. Tumor NGS Detection Basic Information
9.15.2 Pacific Biosciences of California Inc. Tumor NGS Detection Product Overview
9.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Product Market Performance
9.15.4 Pacific Biosciences of California Inc. Business Overview
9.15.5 Pacific Biosciences of California Inc. Recent Developments
9.16 Life Technologies Corporation
9.16.1 Life Technologies Corporation Tumor NGS Detection Basic Information
9.16.2 Life Technologies Corporation Tumor NGS Detection Product Overview
9.16.3 Life Technologies Corporation Tumor NGS Detection Product Market Performance
9.16.4 Life Technologies Corporation Business Overview
9.16.5 Life Technologies Corporation Recent Developments
9.17 GTH.O
9.17.1 GTH.O Tumor NGS Detection Basic Information
9.17.2 GTH.O Tumor NGS Detection Product Overview
9.17.3 GTH.O Tumor NGS Detection Product Market Performance
9.17.4 GTH.O Business Overview
9.17.5 GTH.O Recent Developments
9.18 Paradigm Diagnostics
9.18.1 Paradigm Diagnostics Tumor NGS Detection Basic Information
9.18.2 Paradigm Diagnostics Tumor NGS Detection Product Overview
9.18.3 Paradigm Diagnostics Tumor NGS Detection Product Market Performance
9.18.4 Paradigm Diagnostics Business Overview
9.18.5 Paradigm Diagnostics Recent Developments
9.19 Oxford Nanopore Technologies Ltd.
9.19.1 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Basic Information
9.19.2 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Overview
9.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Market Performance
9.19.4 Oxford Nanopore Technologies Ltd. Business Overview
9.19.5 Oxford Nanopore Technologies Ltd. Recent Developments
9.20 Eurofins Scientific S.E.
9.20.1 Eurofins Scientific S.E. Tumor NGS Detection Basic Information
9.20.2 Eurofins Scientific S.E. Tumor NGS Detection Product Overview
9.20.3 Eurofins Scientific S.E. Tumor NGS Detection Product Market Performance
9.20.4 Eurofins Scientific S.E. Business Overview
9.20.5 Eurofins Scientific S.E. Recent Developments
10 TUMOR NGS DETECTION MARKET FORECAST BY REGION
10.1 Global Tumor NGS Detection Market Size Forecast
10.2 Global Tumor NGS Detection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tumor NGS Detection Market Size Forecast by Country
10.2.3 Asia Pacific Tumor NGS Detection Market Size Forecast by Region
10.2.4 South America Tumor NGS Detection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tumor NGS Detection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tumor NGS Detection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tumor NGS Detection by Type (2025-2030)
11.1.2 Global Tumor NGS Detection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tumor NGS Detection by Type (2025-2030)
11.2 Global Tumor NGS Detection Market Forecast by Application (2025-2030)
11.2.1 Global Tumor NGS Detection Sales (K Units) Forecast by Application
11.2.2 Global Tumor NGS Detection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Tumor NGS Detection
1.2 Key Market Segments
1.2.1 Tumor NGS Detection Segment by Type
1.2.2 Tumor NGS Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TUMOR NGS DETECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Tumor NGS Detection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tumor NGS Detection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TUMOR NGS DETECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Tumor NGS Detection Sales by Manufacturers (2019-2024)
3.2 Global Tumor NGS Detection Revenue Market Share by Manufacturers (2019-2024)
3.3 Tumor NGS Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tumor NGS Detection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tumor NGS Detection Sales Sites, Area Served, Product Type
3.6 Tumor NGS Detection Market Competitive Situation and Trends
3.6.1 Tumor NGS Detection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tumor NGS Detection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TUMOR NGS DETECTION INDUSTRY CHAIN ANALYSIS
4.1 Tumor NGS Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TUMOR NGS DETECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TUMOR NGS DETECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor NGS Detection Sales Market Share by Type (2019-2024)
6.3 Global Tumor NGS Detection Market Size Market Share by Type (2019-2024)
6.4 Global Tumor NGS Detection Price by Type (2019-2024)
7 TUMOR NGS DETECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor NGS Detection Market Sales by Application (2019-2024)
7.3 Global Tumor NGS Detection Market Size (M USD) by Application (2019-2024)
7.4 Global Tumor NGS Detection Sales Growth Rate by Application (2019-2024)
8 TUMOR NGS DETECTION MARKET SEGMENTATION BY REGION
8.1 Global Tumor NGS Detection Sales by Region
8.1.1 Global Tumor NGS Detection Sales by Region
8.1.2 Global Tumor NGS Detection Sales Market Share by Region
8.2 North America
8.2.1 North America Tumor NGS Detection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tumor NGS Detection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tumor NGS Detection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tumor NGS Detection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tumor NGS Detection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent
9.1.1 Agilent Tumor NGS Detection Basic Information
9.1.2 Agilent Tumor NGS Detection Product Overview
9.1.3 Agilent Tumor NGS Detection Product Market Performance
9.1.4 Agilent Business Overview
9.1.5 Agilent Tumor NGS Detection SWOT Analysis
9.1.6 Agilent Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Tumor NGS Detection Basic Information
9.2.2 Thermo Fisher Scientific Tumor NGS Detection Product Overview
9.2.3 Thermo Fisher Scientific Tumor NGS Detection Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific Tumor NGS Detection SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 BGI Group
9.3.1 BGI Group Tumor NGS Detection Basic Information
9.3.2 BGI Group Tumor NGS Detection Product Overview
9.3.3 BGI Group Tumor NGS Detection Product Market Performance
9.3.4 BGI Group Tumor NGS Detection SWOT Analysis
9.3.5 BGI Group Business Overview
9.3.6 BGI Group Recent Developments
9.4 Roche Foundation Medicine
9.4.1 Roche Foundation Medicine Tumor NGS Detection Basic Information
9.4.2 Roche Foundation Medicine Tumor NGS Detection Product Overview
9.4.3 Roche Foundation Medicine Tumor NGS Detection Product Market Performance
9.4.4 Roche Foundation Medicine Business Overview
9.4.5 Roche Foundation Medicine Recent Developments
9.5 Sinopharm Group
9.5.1 Sinopharm Group Tumor NGS Detection Basic Information
9.5.2 Sinopharm Group Tumor NGS Detection Product Overview
9.5.3 Sinopharm Group Tumor NGS Detection Product Market Performance
9.5.4 Sinopharm Group Business Overview
9.5.5 Sinopharm Group Recent Developments
9.6 Fosunpharma
9.6.1 Fosunpharma Tumor NGS Detection Basic Information
9.6.2 Fosunpharma Tumor NGS Detection Product Overview
9.6.3 Fosunpharma Tumor NGS Detection Product Market Performance
9.6.4 Fosunpharma Business Overview
9.6.5 Fosunpharma Recent Developments
9.7 Novogene
9.7.1 Novogene Tumor NGS Detection Basic Information
9.7.2 Novogene Tumor NGS Detection Product Overview
9.7.3 Novogene Tumor NGS Detection Product Market Performance
9.7.4 Novogene Business Overview
9.7.5 Novogene Recent Developments
9.8 Geneseeq
9.8.1 Geneseeq Tumor NGS Detection Basic Information
9.8.2 Geneseeq Tumor NGS Detection Product Overview
9.8.3 Geneseeq Tumor NGS Detection Product Market Performance
9.8.4 Geneseeq Business Overview
9.8.5 Geneseeq Recent Developments
9.9 AmoyDx
9.9.1 AmoyDx Tumor NGS Detection Basic Information
9.9.2 AmoyDx Tumor NGS Detection Product Overview
9.9.3 AmoyDx Tumor NGS Detection Product Market Performance
9.9.4 AmoyDx Business Overview
9.9.5 AmoyDx Recent Developments
9.10 Burning Rock Medicine
9.10.1 Burning Rock Medicine Tumor NGS Detection Basic Information
9.10.2 Burning Rock Medicine Tumor NGS Detection Product Overview
9.10.3 Burning Rock Medicine Tumor NGS Detection Product Market Performance
9.10.4 Burning Rock Medicine Business Overview
9.10.5 Burning Rock Medicine Recent Developments
9.11 Perkin Elmer
9.11.1 Perkin Elmer Tumor NGS Detection Basic Information
9.11.2 Perkin Elmer Tumor NGS Detection Product Overview
9.11.3 Perkin Elmer Tumor NGS Detection Product Market Performance
9.11.4 Perkin Elmer Business Overview
9.11.5 Perkin Elmer Recent Developments
9.12 Qiagen NV
9.12.1 Qiagen NV Tumor NGS Detection Basic Information
9.12.2 Qiagen NV Tumor NGS Detection Product Overview
9.12.3 Qiagen NV Tumor NGS Detection Product Market Performance
9.12.4 Qiagen NV Business Overview
9.12.5 Qiagen NV Recent Developments
9.13 Partek
9.13.1 Partek Tumor NGS Detection Basic Information
9.13.2 Partek Tumor NGS Detection Product Overview
9.13.3 Partek Tumor NGS Detection Product Market Performance
9.13.4 Partek Business Overview
9.13.5 Partek Recent Developments
9.14 Illumina Inc.
9.14.1 Illumina Inc. Tumor NGS Detection Basic Information
9.14.2 Illumina Inc. Tumor NGS Detection Product Overview
9.14.3 Illumina Inc. Tumor NGS Detection Product Market Performance
9.14.4 Illumina Inc. Business Overview
9.14.5 Illumina Inc. Recent Developments
9.15 Pacific Biosciences of California Inc.
9.15.1 Pacific Biosciences of California Inc. Tumor NGS Detection Basic Information
9.15.2 Pacific Biosciences of California Inc. Tumor NGS Detection Product Overview
9.15.3 Pacific Biosciences of California Inc. Tumor NGS Detection Product Market Performance
9.15.4 Pacific Biosciences of California Inc. Business Overview
9.15.5 Pacific Biosciences of California Inc. Recent Developments
9.16 Life Technologies Corporation
9.16.1 Life Technologies Corporation Tumor NGS Detection Basic Information
9.16.2 Life Technologies Corporation Tumor NGS Detection Product Overview
9.16.3 Life Technologies Corporation Tumor NGS Detection Product Market Performance
9.16.4 Life Technologies Corporation Business Overview
9.16.5 Life Technologies Corporation Recent Developments
9.17 GTH.O
9.17.1 GTH.O Tumor NGS Detection Basic Information
9.17.2 GTH.O Tumor NGS Detection Product Overview
9.17.3 GTH.O Tumor NGS Detection Product Market Performance
9.17.4 GTH.O Business Overview
9.17.5 GTH.O Recent Developments
9.18 Paradigm Diagnostics
9.18.1 Paradigm Diagnostics Tumor NGS Detection Basic Information
9.18.2 Paradigm Diagnostics Tumor NGS Detection Product Overview
9.18.3 Paradigm Diagnostics Tumor NGS Detection Product Market Performance
9.18.4 Paradigm Diagnostics Business Overview
9.18.5 Paradigm Diagnostics Recent Developments
9.19 Oxford Nanopore Technologies Ltd.
9.19.1 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Basic Information
9.19.2 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Overview
9.19.3 Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Market Performance
9.19.4 Oxford Nanopore Technologies Ltd. Business Overview
9.19.5 Oxford Nanopore Technologies Ltd. Recent Developments
9.20 Eurofins Scientific S.E.
9.20.1 Eurofins Scientific S.E. Tumor NGS Detection Basic Information
9.20.2 Eurofins Scientific S.E. Tumor NGS Detection Product Overview
9.20.3 Eurofins Scientific S.E. Tumor NGS Detection Product Market Performance
9.20.4 Eurofins Scientific S.E. Business Overview
9.20.5 Eurofins Scientific S.E. Recent Developments
10 TUMOR NGS DETECTION MARKET FORECAST BY REGION
10.1 Global Tumor NGS Detection Market Size Forecast
10.2 Global Tumor NGS Detection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tumor NGS Detection Market Size Forecast by Country
10.2.3 Asia Pacific Tumor NGS Detection Market Size Forecast by Region
10.2.4 South America Tumor NGS Detection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tumor NGS Detection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Tumor NGS Detection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tumor NGS Detection by Type (2025-2030)
11.1.2 Global Tumor NGS Detection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tumor NGS Detection by Type (2025-2030)
11.2 Global Tumor NGS Detection Market Forecast by Application (2025-2030)
11.2.1 Global Tumor NGS Detection Sales (K Units) Forecast by Application
11.2.2 Global Tumor NGS Detection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor NGS Detection Market Size Comparison by Region (M USD)
Table 5. Global Tumor NGS Detection Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Tumor NGS Detection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tumor NGS Detection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tumor NGS Detection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor NGS Detection as of 2022)
Table 10. Global Market Tumor NGS Detection Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tumor NGS Detection Sales Sites and Area Served
Table 12. Manufacturers Tumor NGS Detection Product Type
Table 13. Global Tumor NGS Detection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tumor NGS Detection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tumor NGS Detection Market Challenges
Table 22. Global Tumor NGS Detection Sales by Type (K Units)
Table 23. Global Tumor NGS Detection Market Size by Type (M USD)
Table 24. Global Tumor NGS Detection Sales (K Units) by Type (2019-2024)
Table 25. Global Tumor NGS Detection Sales Market Share by Type (2019-2024)
Table 26. Global Tumor NGS Detection Market Size (M USD) by Type (2019-2024)
Table 27. Global Tumor NGS Detection Market Size Share by Type (2019-2024)
Table 28. Global Tumor NGS Detection Price (USD/Unit) by Type (2019-2024)
Table 29. Global Tumor NGS Detection Sales (K Units) by Application
Table 30. Global Tumor NGS Detection Market Size by Application
Table 31. Global Tumor NGS Detection Sales by Application (2019-2024) & (K Units)
Table 32. Global Tumor NGS Detection Sales Market Share by Application (2019-2024)
Table 33. Global Tumor NGS Detection Sales by Application (2019-2024) & (M USD)
Table 34. Global Tumor NGS Detection Market Share by Application (2019-2024)
Table 35. Global Tumor NGS Detection Sales Growth Rate by Application (2019-2024)
Table 36. Global Tumor NGS Detection Sales by Region (2019-2024) & (K Units)
Table 37. Global Tumor NGS Detection Sales Market Share by Region (2019-2024)
Table 38. North America Tumor NGS Detection Sales by Country (2019-2024) & (K Units)
Table 39. Europe Tumor NGS Detection Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Tumor NGS Detection Sales by Region (2019-2024) & (K Units)
Table 41. South America Tumor NGS Detection Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Tumor NGS Detection Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Tumor NGS Detection Basic Information
Table 44. Agilent Tumor NGS Detection Product Overview
Table 45. Agilent Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Business Overview
Table 47. Agilent Tumor NGS Detection SWOT Analysis
Table 48. Agilent Recent Developments
Table 49. Thermo Fisher Scientific Tumor NGS Detection Basic Information
Table 50. Thermo Fisher Scientific Tumor NGS Detection Product Overview
Table 51. Thermo Fisher Scientific Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Tumor NGS Detection SWOT Analysis
Table 54. Thermo Fisher Scientific Recent Developments
Table 55. BGI Group Tumor NGS Detection Basic Information
Table 56. BGI Group Tumor NGS Detection Product Overview
Table 57. BGI Group Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BGI Group Tumor NGS Detection SWOT Analysis
Table 59. BGI Group Business Overview
Table 60. BGI Group Recent Developments
Table 61. Roche Foundation Medicine Tumor NGS Detection Basic Information
Table 62. Roche Foundation Medicine Tumor NGS Detection Product Overview
Table 63. Roche Foundation Medicine Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Roche Foundation Medicine Business Overview
Table 65. Roche Foundation Medicine Recent Developments
Table 66. Sinopharm Group Tumor NGS Detection Basic Information
Table 67. Sinopharm Group Tumor NGS Detection Product Overview
Table 68. Sinopharm Group Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sinopharm Group Business Overview
Table 70. Sinopharm Group Recent Developments
Table 71. Fosunpharma Tumor NGS Detection Basic Information
Table 72. Fosunpharma Tumor NGS Detection Product Overview
Table 73. Fosunpharma Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Fosunpharma Business Overview
Table 75. Fosunpharma Recent Developments
Table 76. Novogene Tumor NGS Detection Basic Information
Table 77. Novogene Tumor NGS Detection Product Overview
Table 78. Novogene Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Novogene Business Overview
Table 80. Novogene Recent Developments
Table 81. Geneseeq Tumor NGS Detection Basic Information
Table 82. Geneseeq Tumor NGS Detection Product Overview
Table 83. Geneseeq Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Geneseeq Business Overview
Table 85. Geneseeq Recent Developments
Table 86. AmoyDx Tumor NGS Detection Basic Information
Table 87. AmoyDx Tumor NGS Detection Product Overview
Table 88. AmoyDx Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. AmoyDx Business Overview
Table 90. AmoyDx Recent Developments
Table 91. Burning Rock Medicine Tumor NGS Detection Basic Information
Table 92. Burning Rock Medicine Tumor NGS Detection Product Overview
Table 93. Burning Rock Medicine Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Burning Rock Medicine Business Overview
Table 95. Burning Rock Medicine Recent Developments
Table 96. Perkin Elmer Tumor NGS Detection Basic Information
Table 97. Perkin Elmer Tumor NGS Detection Product Overview
Table 98. Perkin Elmer Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Perkin Elmer Business Overview
Table 100. Perkin Elmer Recent Developments
Table 101. Qiagen NV Tumor NGS Detection Basic Information
Table 102. Qiagen NV Tumor NGS Detection Product Overview
Table 103. Qiagen NV Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Qiagen NV Business Overview
Table 105. Qiagen NV Recent Developments
Table 106. Partek Tumor NGS Detection Basic Information
Table 107. Partek Tumor NGS Detection Product Overview
Table 108. Partek Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Partek Business Overview
Table 110. Partek Recent Developments
Table 111. Illumina Inc. Tumor NGS Detection Basic Information
Table 112. Illumina Inc. Tumor NGS Detection Product Overview
Table 113. Illumina Inc. Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Illumina Inc. Business Overview
Table 115. Illumina Inc. Recent Developments
Table 116. Pacific Biosciences of California Inc. Tumor NGS Detection Basic Information
Table 117. Pacific Biosciences of California Inc. Tumor NGS Detection Product Overview
Table 118. Pacific Biosciences of California Inc. Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Pacific Biosciences of California Inc. Business Overview
Table 120. Pacific Biosciences of California Inc. Recent Developments
Table 121. Life Technologies Corporation Tumor NGS Detection Basic Information
Table 122. Life Technologies Corporation Tumor NGS Detection Product Overview
Table 123. Life Technologies Corporation Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Life Technologies Corporation Business Overview
Table 125. Life Technologies Corporation Recent Developments
Table 126. GTH.O Tumor NGS Detection Basic Information
Table 127. GTH.O Tumor NGS Detection Product Overview
Table 128. GTH.O Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. GTH.O Business Overview
Table 130. GTH.O Recent Developments
Table 131. Paradigm Diagnostics Tumor NGS Detection Basic Information
Table 132. Paradigm Diagnostics Tumor NGS Detection Product Overview
Table 133. Paradigm Diagnostics Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Paradigm Diagnostics Business Overview
Table 135. Paradigm Diagnostics Recent Developments
Table 136. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Basic Information
Table 137. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Overview
Table 138. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Oxford Nanopore Technologies Ltd. Business Overview
Table 140. Oxford Nanopore Technologies Ltd. Recent Developments
Table 141. Eurofins Scientific S.E. Tumor NGS Detection Basic Information
Table 142. Eurofins Scientific S.E. Tumor NGS Detection Product Overview
Table 143. Eurofins Scientific S.E. Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Eurofins Scientific S.E. Business Overview
Table 145. Eurofins Scientific S.E. Recent Developments
Table 146. Global Tumor NGS Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Tumor NGS Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Tumor NGS Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Tumor NGS Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Tumor NGS Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Tumor NGS Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Tumor NGS Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Tumor NGS Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Tumor NGS Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Tumor NGS Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Tumor NGS Detection Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Tumor NGS Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Tumor NGS Detection Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Tumor NGS Detection Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Tumor NGS Detection Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Tumor NGS Detection Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Tumor NGS Detection Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor NGS Detection Market Size Comparison by Region (M USD)
Table 5. Global Tumor NGS Detection Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Tumor NGS Detection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tumor NGS Detection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tumor NGS Detection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor NGS Detection as of 2022)
Table 10. Global Market Tumor NGS Detection Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tumor NGS Detection Sales Sites and Area Served
Table 12. Manufacturers Tumor NGS Detection Product Type
Table 13. Global Tumor NGS Detection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tumor NGS Detection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tumor NGS Detection Market Challenges
Table 22. Global Tumor NGS Detection Sales by Type (K Units)
Table 23. Global Tumor NGS Detection Market Size by Type (M USD)
Table 24. Global Tumor NGS Detection Sales (K Units) by Type (2019-2024)
Table 25. Global Tumor NGS Detection Sales Market Share by Type (2019-2024)
Table 26. Global Tumor NGS Detection Market Size (M USD) by Type (2019-2024)
Table 27. Global Tumor NGS Detection Market Size Share by Type (2019-2024)
Table 28. Global Tumor NGS Detection Price (USD/Unit) by Type (2019-2024)
Table 29. Global Tumor NGS Detection Sales (K Units) by Application
Table 30. Global Tumor NGS Detection Market Size by Application
Table 31. Global Tumor NGS Detection Sales by Application (2019-2024) & (K Units)
Table 32. Global Tumor NGS Detection Sales Market Share by Application (2019-2024)
Table 33. Global Tumor NGS Detection Sales by Application (2019-2024) & (M USD)
Table 34. Global Tumor NGS Detection Market Share by Application (2019-2024)
Table 35. Global Tumor NGS Detection Sales Growth Rate by Application (2019-2024)
Table 36. Global Tumor NGS Detection Sales by Region (2019-2024) & (K Units)
Table 37. Global Tumor NGS Detection Sales Market Share by Region (2019-2024)
Table 38. North America Tumor NGS Detection Sales by Country (2019-2024) & (K Units)
Table 39. Europe Tumor NGS Detection Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Tumor NGS Detection Sales by Region (2019-2024) & (K Units)
Table 41. South America Tumor NGS Detection Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Tumor NGS Detection Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Tumor NGS Detection Basic Information
Table 44. Agilent Tumor NGS Detection Product Overview
Table 45. Agilent Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Business Overview
Table 47. Agilent Tumor NGS Detection SWOT Analysis
Table 48. Agilent Recent Developments
Table 49. Thermo Fisher Scientific Tumor NGS Detection Basic Information
Table 50. Thermo Fisher Scientific Tumor NGS Detection Product Overview
Table 51. Thermo Fisher Scientific Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Tumor NGS Detection SWOT Analysis
Table 54. Thermo Fisher Scientific Recent Developments
Table 55. BGI Group Tumor NGS Detection Basic Information
Table 56. BGI Group Tumor NGS Detection Product Overview
Table 57. BGI Group Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BGI Group Tumor NGS Detection SWOT Analysis
Table 59. BGI Group Business Overview
Table 60. BGI Group Recent Developments
Table 61. Roche Foundation Medicine Tumor NGS Detection Basic Information
Table 62. Roche Foundation Medicine Tumor NGS Detection Product Overview
Table 63. Roche Foundation Medicine Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Roche Foundation Medicine Business Overview
Table 65. Roche Foundation Medicine Recent Developments
Table 66. Sinopharm Group Tumor NGS Detection Basic Information
Table 67. Sinopharm Group Tumor NGS Detection Product Overview
Table 68. Sinopharm Group Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sinopharm Group Business Overview
Table 70. Sinopharm Group Recent Developments
Table 71. Fosunpharma Tumor NGS Detection Basic Information
Table 72. Fosunpharma Tumor NGS Detection Product Overview
Table 73. Fosunpharma Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Fosunpharma Business Overview
Table 75. Fosunpharma Recent Developments
Table 76. Novogene Tumor NGS Detection Basic Information
Table 77. Novogene Tumor NGS Detection Product Overview
Table 78. Novogene Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Novogene Business Overview
Table 80. Novogene Recent Developments
Table 81. Geneseeq Tumor NGS Detection Basic Information
Table 82. Geneseeq Tumor NGS Detection Product Overview
Table 83. Geneseeq Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Geneseeq Business Overview
Table 85. Geneseeq Recent Developments
Table 86. AmoyDx Tumor NGS Detection Basic Information
Table 87. AmoyDx Tumor NGS Detection Product Overview
Table 88. AmoyDx Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. AmoyDx Business Overview
Table 90. AmoyDx Recent Developments
Table 91. Burning Rock Medicine Tumor NGS Detection Basic Information
Table 92. Burning Rock Medicine Tumor NGS Detection Product Overview
Table 93. Burning Rock Medicine Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Burning Rock Medicine Business Overview
Table 95. Burning Rock Medicine Recent Developments
Table 96. Perkin Elmer Tumor NGS Detection Basic Information
Table 97. Perkin Elmer Tumor NGS Detection Product Overview
Table 98. Perkin Elmer Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Perkin Elmer Business Overview
Table 100. Perkin Elmer Recent Developments
Table 101. Qiagen NV Tumor NGS Detection Basic Information
Table 102. Qiagen NV Tumor NGS Detection Product Overview
Table 103. Qiagen NV Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Qiagen NV Business Overview
Table 105. Qiagen NV Recent Developments
Table 106. Partek Tumor NGS Detection Basic Information
Table 107. Partek Tumor NGS Detection Product Overview
Table 108. Partek Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Partek Business Overview
Table 110. Partek Recent Developments
Table 111. Illumina Inc. Tumor NGS Detection Basic Information
Table 112. Illumina Inc. Tumor NGS Detection Product Overview
Table 113. Illumina Inc. Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Illumina Inc. Business Overview
Table 115. Illumina Inc. Recent Developments
Table 116. Pacific Biosciences of California Inc. Tumor NGS Detection Basic Information
Table 117. Pacific Biosciences of California Inc. Tumor NGS Detection Product Overview
Table 118. Pacific Biosciences of California Inc. Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Pacific Biosciences of California Inc. Business Overview
Table 120. Pacific Biosciences of California Inc. Recent Developments
Table 121. Life Technologies Corporation Tumor NGS Detection Basic Information
Table 122. Life Technologies Corporation Tumor NGS Detection Product Overview
Table 123. Life Technologies Corporation Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Life Technologies Corporation Business Overview
Table 125. Life Technologies Corporation Recent Developments
Table 126. GTH.O Tumor NGS Detection Basic Information
Table 127. GTH.O Tumor NGS Detection Product Overview
Table 128. GTH.O Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. GTH.O Business Overview
Table 130. GTH.O Recent Developments
Table 131. Paradigm Diagnostics Tumor NGS Detection Basic Information
Table 132. Paradigm Diagnostics Tumor NGS Detection Product Overview
Table 133. Paradigm Diagnostics Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Paradigm Diagnostics Business Overview
Table 135. Paradigm Diagnostics Recent Developments
Table 136. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Basic Information
Table 137. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Product Overview
Table 138. Oxford Nanopore Technologies Ltd. Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Oxford Nanopore Technologies Ltd. Business Overview
Table 140. Oxford Nanopore Technologies Ltd. Recent Developments
Table 141. Eurofins Scientific S.E. Tumor NGS Detection Basic Information
Table 142. Eurofins Scientific S.E. Tumor NGS Detection Product Overview
Table 143. Eurofins Scientific S.E. Tumor NGS Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Eurofins Scientific S.E. Business Overview
Table 145. Eurofins Scientific S.E. Recent Developments
Table 146. Global Tumor NGS Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Tumor NGS Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Tumor NGS Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Tumor NGS Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Tumor NGS Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Tumor NGS Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Tumor NGS Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Tumor NGS Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Tumor NGS Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Tumor NGS Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Tumor NGS Detection Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Tumor NGS Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Tumor NGS Detection Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Tumor NGS Detection Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Tumor NGS Detection Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Tumor NGS Detection Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Tumor NGS Detection Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Tumor NGS Detection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor NGS Detection Market Size (M USD), 2019-2030
Figure 5. Global Tumor NGS Detection Market Size (M USD) (2019-2030)
Figure 6. Global Tumor NGS Detection Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor NGS Detection Market Size by Country (M USD)
Figure 11. Tumor NGS Detection Sales Share by Manufacturers in 2023
Figure 12. Global Tumor NGS Detection Revenue Share by Manufacturers in 2023
Figure 13. Tumor NGS Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tumor NGS Detection Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tumor NGS Detection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tumor NGS Detection Market Share by Type
Figure 18. Sales Market Share of Tumor NGS Detection by Type (2019-2024)
Figure 19. Sales Market Share of Tumor NGS Detection by Type in 2023
Figure 20. Market Size Share of Tumor NGS Detection by Type (2019-2024)
Figure 21. Market Size Market Share of Tumor NGS Detection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tumor NGS Detection Market Share by Application
Figure 24. Global Tumor NGS Detection Sales Market Share by Application (2019-2024)
Figure 25. Global Tumor NGS Detection Sales Market Share by Application in 2023
Figure 26. Global Tumor NGS Detection Market Share by Application (2019-2024)
Figure 27. Global Tumor NGS Detection Market Share by Application in 2023
Figure 28. Global Tumor NGS Detection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tumor NGS Detection Sales Market Share by Region (2019-2024)
Figure 30. North America Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Tumor NGS Detection Sales Market Share by Country in 2023
Figure 32. U.S. Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Tumor NGS Detection Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Tumor NGS Detection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Tumor NGS Detection Sales Market Share by Country in 2023
Figure 37. Germany Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Tumor NGS Detection Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Tumor NGS Detection Sales Market Share by Region in 2023
Figure 44. China Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Tumor NGS Detection Sales and Growth Rate (K Units)
Figure 50. South America Tumor NGS Detection Sales Market Share by Country in 2023
Figure 51. Brazil Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Tumor NGS Detection Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Tumor NGS Detection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Tumor NGS Detection Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Tumor NGS Detection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tumor NGS Detection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tumor NGS Detection Market Share Forecast by Type (2025-2030)
Figure 65. Global Tumor NGS Detection Sales Forecast by Application (2025-2030)
Figure 66. Global Tumor NGS Detection Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Tumor NGS Detection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor NGS Detection Market Size (M USD), 2019-2030
Figure 5. Global Tumor NGS Detection Market Size (M USD) (2019-2030)
Figure 6. Global Tumor NGS Detection Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor NGS Detection Market Size by Country (M USD)
Figure 11. Tumor NGS Detection Sales Share by Manufacturers in 2023
Figure 12. Global Tumor NGS Detection Revenue Share by Manufacturers in 2023
Figure 13. Tumor NGS Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tumor NGS Detection Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tumor NGS Detection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tumor NGS Detection Market Share by Type
Figure 18. Sales Market Share of Tumor NGS Detection by Type (2019-2024)
Figure 19. Sales Market Share of Tumor NGS Detection by Type in 2023
Figure 20. Market Size Share of Tumor NGS Detection by Type (2019-2024)
Figure 21. Market Size Market Share of Tumor NGS Detection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tumor NGS Detection Market Share by Application
Figure 24. Global Tumor NGS Detection Sales Market Share by Application (2019-2024)
Figure 25. Global Tumor NGS Detection Sales Market Share by Application in 2023
Figure 26. Global Tumor NGS Detection Market Share by Application (2019-2024)
Figure 27. Global Tumor NGS Detection Market Share by Application in 2023
Figure 28. Global Tumor NGS Detection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tumor NGS Detection Sales Market Share by Region (2019-2024)
Figure 30. North America Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Tumor NGS Detection Sales Market Share by Country in 2023
Figure 32. U.S. Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Tumor NGS Detection Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Tumor NGS Detection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Tumor NGS Detection Sales Market Share by Country in 2023
Figure 37. Germany Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Tumor NGS Detection Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Tumor NGS Detection Sales Market Share by Region in 2023
Figure 44. China Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Tumor NGS Detection Sales and Growth Rate (K Units)
Figure 50. South America Tumor NGS Detection Sales Market Share by Country in 2023
Figure 51. Brazil Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Tumor NGS Detection Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Tumor NGS Detection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Tumor NGS Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Tumor NGS Detection Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Tumor NGS Detection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tumor NGS Detection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tumor NGS Detection Market Share Forecast by Type (2025-2030)
Figure 65. Global Tumor NGS Detection Sales Forecast by Application (2025-2030)
Figure 66. Global Tumor NGS Detection Market Share Forecast by Application (2025-2030)
